BioNexus Gene Lab Corp.

BGLC · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$4,377$5,929$2,119$2,124
Short-Term Investments$0$0$0$0
Receivables$1,580$857$2,900$3,357
Inventory$1,389$1,138$978$1,522
Other Curr. Assets$84$122$25$80
Total Curr. Assets$7,430$8,047$6,022$7,082
Property Plant & Equip (Net)$1,738$1,653$1,567$1,676
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$1,265$1,700$1,151$749
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$68
Total NC Assets$3,003$3,353$2,718$2,492
Other Assets$0$0$0$0
Total Assets$10,434$11,400$8,740$9,574
Liabilities
Payables$1,503$1,402$1,861$2,012
Short-Term Debt$51$48$17$40
Tax Payable$0$0$0$98
Deferred Revenue$96$0$23$108
Other Curr. Liab.$301$181$103$72
Total Curr. Liab.$1,951$1,631$2,004$2,329
LT Debt$160$99$40$37
Deferred Rev, NC$0-$12$0$0
Deferred Tax Liab, NC$0$12$31$28
Other NC Liab.$0$12$0$0
Total NC Liab.$160$111$71$66
Other Liabilities$0$0$0$0
Cap. Leases$211$133$40$37
Total Liabilities$2,111$1,742$2,075$2,395
Equity
Pref Stock$0$0$0$0
Common Stock$17,332$17,191$10,930$10,780
Retained Earnings-$3,443-$1,844$1,156$1,512
AOCI-$555-$677-$409-$100
Other Equity-$5,012-$5,012-$5,012-$5,012
Total Equity$8,323$9,658$6,665$7,180
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$10,434$11,400$8,740$9,574
Net Debt-$4,167-$5,783-$2,062-$2,047